| [1] | Hunter CA, Sibley LD (2012) Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 10: 766–778. doi: 10.1038/nrmicro2858. pmid:23070557
|
| [2] | Dickerson F, Stallings C, Origoni A, Katsafanas E, Schweinfurth L, et al. (2014) Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J Nerv Ment Dis 202: 589–593. doi: 10.1097/NMD.0000000000000166. pmid:25010110
|
| [3] | Suzuki Y, Orellana MA, Schreiber RD, Remington JS (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240: 516–518. pmid:3128869 doi: 10.1126/science.3128869
|
| [4] | Suzuki Y, Remington JS (1988) Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol 140: 3943–3946. pmid:3259601
|
| [5] | Denkers EY, Gazzinelli RT, Martin D, Sher A (1993) Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med 178: 1465–1472. pmid:8228800 doi: 10.1084/jem.178.5.1465
|
| [6] | Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, et al. (2013) Innate lymphoid cells—a proposal for uniform nomenclature. Nat Rev Immunol 13: 145–149. doi: 10.1038/nri3365. pmid:23348417
|
| [7] | Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23: 225–274. pmid:15771571 doi: 10.1146/annurev.immunol.23.021704.115526
|
| [8] | Daeron M, Jaeger S, Du Pasquier L, Vivier E (2008) Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 224: 11–43. doi: 10.1111/j.1600-065X.2008.00666.x. pmid:18759918
|
| [9] | Herberman RB, Nunn ME, Lavrin DH (1975) Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16: 216–229. pmid:50294 doi: 10.1002/ijc.2910160204
|
| [10] | Kamiyama T, Hagiwara T (1982) Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii. Infect Immun 36: 628–636. pmid:6177634
|
| [11] | Hauser WE Jr., Sharma SD, Remington JS (1982) Natural killer cells induced by acute and chronic toxoplasma infection. Cell Immunol 69: 330–346. pmid:6980721 doi: 10.1016/0008-8749(82)90076-4
|
| [12] | Hauser WE Jr., Sharma SD, Remington JS (1983) Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii. J Immunol 131: 458–463. pmid:6190921
|
| [13] | Sharma SD, Verhoef J, Remington JS (1984) Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii. Cell Immunol 86: 317–326. pmid:6587935 doi: 10.1016/0008-8749(84)90386-1
|
| [14] | Sher A, Oswald IP, Hieny S, Gazzinelli RT (1993) Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. J Immunol 150: 3982–3989. pmid:8473745
|
| [15] | Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, et al. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159: 1903–1908. pmid:9257855
|
| [16] | Baird JR, Byrne KT, Lizotte PH, Toraya-Brown S, Scarlett UK, et al. (2013) Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol 190: 469–478. doi: 10.4049/jimmunol.1201209. pmid:23225891
|
| [17] | O'Brien KB, Schultz-Cherry S, Knoll LJ (2011) Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection. J Virol 85: 8680–8688. doi: 10.1128/JVI.05142-11. pmid:21734055
|
| [18] | Passos ST, Silver JS, O'Hara AC, Sehy D, Stumhofer JS, et al. (2010) IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol 184: 1776–1783. doi: 10.4049/jimmunol.0901843. pmid:20083665
|
| [19] | Combe CL, Curiel TJ, Moretto MM, Khan IA (2005) NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect Immun 73: 4913–4921. pmid:16041005 doi: 10.1128/iai.73.8.4913-4921.2005
|
| [20] | Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, et al. (2012) NK cell-derived interferon-gamma orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36: 1047–1059. doi: 10.1016/j.immuni.2012.03.026. pmid:22749354
|
| [21] | Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A (1993) Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A 90: 6115–6119. pmid:8100999 doi: 10.1073/pnas.90.13.6115
|
| [22] | Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 62: 2818–2824. pmid:7911785
|
| [23] | Hunter CA, Chizzonite R, Remington JS (1995) IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 155: 4347–4354. pmid:7594594
|
| [24] | Hunter CA, Gabriel KE, Radzanowski T, Neyer LE, Remington JS (1997) Type I interferons enhance production of IFN-gamma by NK cells. Immunol Lett 59: 1–5. pmid:9334850 doi: 10.1016/s0165-2478(97)00091-6
|
| [25] | Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA (2000) Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol 165: 2619–2627. pmid:10946290 doi: 10.4049/jimmunol.165.5.2619
|
| [26] | Lieberman LA, Villegas EN, Hunter CA (2004) Interleukin-15-deficient mice develop protective immunity to Toxoplasma gondii. Infect Immun 72: 6729–6732. pmid:15501812 doi: 10.1128/iai.72.11.6729-6732.2004
|
| [27] | Hunter CA, Ellis-Neyer L, Gabriel KE, Kennedy MK, Grabstein KH, et al. (1997) The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J Immunol 158: 2285–2293. pmid:9036976
|
| [28] | Tato CM, Mason N, Artis D, Shapira S, Caamano JC, et al. (2006) Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma. Int Immunol 18: 505–513. pmid:16481345 doi: 10.1093/intimm/dxh391
|
| [29] | Harms Pritchard G, Hall AO, Christian DA, Wagage S, Fang Q, et al. (2015) Diverse roles for T-bet in the effector responses required for resistance to infection. J Immunol 194: 1131–1140. doi: 10.4049/jimmunol.1401617. pmid:25556247
|
| [30] | Goldszmid RS, Bafica A, Jankovic D, Feng CG, Caspar P, et al. (2007) TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J Exp Med 204: 2591–2602. pmid:17923502 doi: 10.1084/jem.20070634
|
| [31] | Guan H, Moretto M, Bzik DJ, Gigley J, Khan IA (2007) NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway. J Immunol 179: 590–596. pmid:17579080 doi: 10.4049/jimmunol.179.1.590
|
| [32] | Klose CS, Flach M, Mohle L, Rogell L, Hoyler T, et al. (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157: 340–356. doi: 10.1016/j.cell.2014.03.030. pmid:24725403
|
| [33] | Vivier E, Ugolini S (2009) Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response. Cell Host Microbe 6: 493–495. doi: 10.1016/j.chom.2009.12.001. pmid:20006835
|
| [34] | Perona-Wright G, Mohrs K, Szaba FM, Kummer LW, Madan R, et al. (2009) Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 6: 503–512. doi: 10.1016/j.chom.2009.11.003. pmid:20006839
|
| [35] | Wagage S, John B, Krock BL, Hall AO, Randall LM, et al. (2014) The aryl hydrocarbon receptor promotes IL-10 production by NK cells. J Immunol 192: 1661–1670. doi: 10.4049/jimmunol.1300497. pmid:24403534
|
| [36] | Askenase MH, Han SJ, Byrd AL, Morais da Fonseca D, Bouladoux N, et al. (2015) Bone-Marrow-Resident NK Cells Prime Monocytes for Regulatory Function during Infection. Immunity 42: 1130–1142. doi: 10.1016/j.immuni.2015.05.011. pmid:26070484
|
| [37] | Sun JC, Ugolini S, Vivier E (2014) Immunological memory within the innate immune system. EMBO J 33: 1295–1303. doi: 10.1002/embj.201387651. pmid:24674969
|
| [38] | Foley B, Cooley S, Verneris MR, Curtsinger J, Luo X, et al. (2012) Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol 189: 5082–5088. doi: 10.4049/jimmunol.1201964. pmid:23077239
|
